Atomo Diagnostics featured in Stockhead article on point-of-care medical testing
Atomo Diagnostics has been featured in a recent Stockhead article, “ASX companies behind faster point-of-care medical testing”, published on 28 October 2026.
Posts about:
Atomo Diagnostics has been featured in a recent Stockhead article, “ASX companies behind faster point-of-care medical testing”, published on 28 October 2026.
In today’s fast-paced healthcare environment, and off the back of a changes to the acceptability of at-home testing brought about by the COVID pandemic, the demand for accessible, accurate, and user-friendly diagnostics is growing. Among the most impactful tools in this space are rapid diagnostic tests (RDTs) that can be used in community and at-home settings without the need for clinical intervention; simple, point-of-care tests designed to deliver quick results for a range of conditions, from infectious diseases like HIV and syphilis to general health monitoring for iron deficiency and of course for pregnancy.
In the rapidly evolving field of diagnostics, Atomo’s Pascal Test Cassette stands out as a game-changer. Designed to enhance performance and usability in point-of-care and self-testing, this innovative solution offers a range of features that set it apart from traditional diagnostic tools. Here’s a deep dive into the remarkable capabilities of the Pascal Test Cassette and how it compares to conventional lateral flow kits.